Abstract:Abstract Background Penicillin allergy labels (PALs) influence antibiotic prescribing, yet little is known about the quality and management of PALs placed in the pediatric outpatient setting. Methods We performed a retrospective chart review of 500 randomly selected children with PALs from a ten-year birth cohort (n=18,015) from Texas Children’s Pediatrics and Children’s Hospital of Philadelphia Primary Care Networks. PALs were classified as “not allergy” (family history, isolated diarrhea), “low risk” (maculopapular rash >24 hours into antibiotic course, no hives or pruritis), “moderate or high risk” (hives or pruritis, maculopapular rash < 24 hours into antibiotic course, anaphylaxis, swelling, or respiratory symptoms), “severe cutaneous reaction” (erythema multiforme, serum sickness), or “unable to classify” (information not available or unspecified rash characteristics or timing) based on 1) information in the allergy tab and 2) encounter notes. We used kappa-statistic measure-of-agreement to determine allergy classification agreement between the allergy tab and notes. Results The median age of PAL placement was 1.4 years (IQR 0.9, 2.2). Most (n=303, 63%) PALs were placed by physicians. Half of PALs were categorized as “unable to classify; physicians were just as likely to place ambiguous PALs as other providers (48 vs 53%, p=0.31). Most (80%) children were evaluated at a primary care office within 1 week of their reaction. There was fair agreement between the allergy tab and encounter note documentation (Table 1). Of 54 (11%) children evaluated by an allergist, 25/25 passed an oral amoxicillin challenge. Only 69 (14%) children were de-labeled during the study period, more by an allergist (48%) than in the community (9.6%, p< 0.001). Table 1.Risk stratification by penicillin allergy label and notes. Conclusion PAL classification was ambiguous in half of labeled children; there was fair risk classification agreement between the allergy tab and notes. Children with PALs were rarely referred to allergists or de-labeled in the community. Future quality improvement efforts should seek to improve PAL documentation and access to allergy services. Disclosures Debra Palazzi, MD, MEd, AAP: Board Member|AHRQ: Grant/Research Support|AMA: Board Member|Elsevier: Honoraria.

Beta‐lactam allergy risk stratification in a maternity population in Australia: Scope for allergy de‐labelling

Improving inpatient paediatric de-labelling of allergies to beta-lactams: a quality improvement study

Antepartum vs postpartum amoxicillin oral challenge in pregnant patients with a reported penicillin allergy: A two-center prospective cohort study

Promoting penicillin allergy de‐labeling for children attending a hematology clinic

The appropriateness of penicillin allergy de-labelling by non-allergist clinical ward teams

Reliability and validation of an electronic penicillin allergy risk-assessment tool in a pregnant population

Adult penicillin allergy programmes in Australian hospitals: a practical guide from the National Antibiotic Allergy Network

Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels

567. The Quality & Management of Penicillin Allergy Labels in a Pediatric Birth Cohort

Introduction of a penicillin allergy de-labelling program with direct oral challenge and its effects on utilization of beta-lactam antimicrobials: a multicenter retrospective parallel cohort study

The challenge of de‐labeling penicillin allergy

Retrospective study on penicillin allergy delabeling and evaluation of an antibiotic allergy assessment tool

Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations

Implementation and outcomes of beta-lactam allergy management protocol at a comprehensive cancer center

Delabelling beta-lactam allergy

[Reevaluation of penicillin allergy labeling, appropriate use of β-lactam antibiotics, and multidrug resistance]

Outcomes in reported penicillin allergic mothers and neonates requiring Group B streptococcal prophylaxis: a retrospective observational cohort study

Is the Anamnesis Enough to De-Label Patients with Reported Beta-Lactam Allergy?

Long waitlists for outpatient drug allergy referrals: An Australian tertiary centre experience

Allergy to beta-lactam antibiotics in children: predictors for a positive oral challenge test

Low-risk cefalexin allergies are associated with inpatient prescribing of second-line non-beta-lactam antibiotics